1 Exact Lane - Madison, WIMaster Planned Life Sciences Campus
Exact Sciences (NASDAQ: EXAS) is experiencing very rapid growth of its flagship product, Cologuard, a noninvasive colorectal cancer screening test. To accommodate projected demand, it was imperative to acquire additional real estate that could provide additional laboratory capacity, space for its growing customer care, IT and administrative teams, and expansion area for future growth.
General Capital assisted Exact Sciences in selecting an optimal location, strategic planning, due diligence, a fast track entitlements process, and capital structuring. Phase 1, starting in Fall 2017, will include a ground-up 133,000 square foot diagnostic lab and the renovation of the first floor of the former 150,000 square foot Spectrum Brands office building. Future phases will include complete remodeling of the office building and ground-up construction of a production lab, amenities building and parking deck.
- Mission critical development
- Complex requirements
- Fast track process